GE Healthcare Announces Strategic Partnerships With Process Analysis And Automation And Matrical To Extend Its High Content Analysis-Offerings
As PAA is a specialist in the automation field, this partnership will allow GE Healthcare to provide customers with a range of automation solutions for the company's IN Cell Analyzer and LEADseeker platforms. Components are matched, installations are co-ordinated and customers no longer have to work with multiple vendors to build an automation platform for high content analysis (HCA) and high throughput screening (HTS).
With the strategic supplier agreement with MatriCal, GE Healthcare can now offer 96 and 384 well, flat glass bottom microwell plates at a competitive rate. The flat glass bottom MatriPlates™ have the benefit of providing, low auto-fluorescence, evenness of the plate surface, and optimum optical viewing surface for cell based assays. Combined with the advanced highly sensitive IN Cell Analyzer imaging platform, optimal imaging performance can be achieved.
"These partnerships and agreements allow GE Healthcare to deliver complete solutions to our customers that are able to meet their specific requirements, whether they need automated systems or key accessories for their high content analysis workflow. This will enable customers to undertake cellular analysis with the optimum image quality and the highest efficiency," said Ger Brophy, General Manager of Advanced Systems at GE Healthcare Life Sciences.
About GE Healthcare's IN Cell Analyzer
The IN Cell Analyzer represents a range of modular imaging systems for fast and automated High Content Analysis (HCA). The advanced and highly sensitive platforms enable scientists to study cellular processes in their true biological context, in research and drug discovery. GE offers high-throughput microscopy in combination with modern cellular assays and robotic handling for automated cellular imaging and analysis. The IN Cell Analyzer provides one of the most versatile HCA portfolios on the market and is exceptional in its modularity, completeness and ease of use. It has been recognised by the 2007 Frost & Sullivan Technology Innovation Award. For more detailed information on the IN Cell suite, visit http://www.gelifesciences.com/incell
About PAA
Working in the area of laboratory automation for over 10 years, Process Analysis & Automation Ltd (PAA) has developed hardware and software laboratory automation solutions for over 100 of the worlds leading pharmaceutical and biotechnology companies in USA, Europe and Asia. Our key software product is Overlord2, which allows integration of over 230 laboratory instruments with a range of robots, robotic handlers and stackers. With full data handling, data reduction and databasing capabilities, Overlord2 provides the tools to completely automate laboratory processes. PAA has worked with GE Healthcare for the last five years, offering automated plate handling accessories for the IN Cell 1000, IN Cell 3000 and LEADseeker platforms.
http://www.paa.co.uk
About MatriCal
MatriCal, Inc. is a worldwide supplier of lab instrumentation and consumables for the life science research market based in Spokane, Washington. The company designs and manufactures specialized consumables including microwell plates (MatriPlates™) for high throughput screening and cell based imaging; industrial automation platforms for sample management and automated cell culture; a plate washer for ELISA & cell based assays; and a bench top sonicator. MatriCal's customers include pharmaceutical and biotechnology companies, academic institutes, major universities, and OEM distribution partners. MatriCal offers quality products that add efficiency, increase productivity and speed the drug discovery process.
http://www.matrical.com
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
GE Healthcare
GE Healthcare Announces parteneriate strategice Cu Procesul de analizã ºi de Automaticã ºi Matrical sã-ºi extindã High Content-Analiza ofertelor - GE Healthcare Announces Strategic Partnerships With Process Analysis And Automation And Matrical To Extend Its High Content Analysis-Offerings - articole medicale engleza - startsanatate